Novartis Transfers Lucentis and Beovu Rights to CMS Vision in China Deal
Novartis (NYSE: NVS) announced on October 27, 2025, the signing of a strategic cooperation agreement...
China Medical System
Jingze Bio and CMS Subsidiary Partner to Commercialize Key Products in Reproduction and Ophthalmology
On September 12, 2025, Jingze Biopharmaceutical (Hefei) Co., Ltd., based in China, and a subsidiary...
AccurEdit Therapeutics Raises $75 M Series A, Secures Strategic Partners for Gene‑Editing Platform
China‑based AccurEdit Therapeutics (Suzhou) Co., Ltd. announced that it has closed a US$75 million Series A financing...
CMS Wins NMPA Green Light for Phase‑3 Trial of MG‑K10 Anti‑IL‑4Rα in Chronic Urticaria
China Medical System Holdings Limited (CMS, HKG: 0867) announced that the National Medical Products Administration...
CMS Announces Phase 3 Success of Ruxolitinib Cream in Atopic Dermatitis
China Medical System Holdings Limited (CMS, HKG: 0867) reported that its Phase 3, randomized, double‑blind, placebo‑controlled...
China Medical System’s ZUNVEYL NDA Accepted by China’s NMPA for Alzheimer’s Treatment
China Medical System Holdings Ltd (CMS; HKG: 0867, SGX: 8A8) announced on July 28, 2025,...
China Medical System’s CMS-D001 Gains NMPA Approval for Atopic Dermatitis Trials
China Medical System Holdings Limited (CMS; HKG: 0867) announced that it has received clinical trial...
CMS Plans Secondary Listing on Singapore Exchange to Enhance Shareholder Base and Liquidity
China Medical System Holdings Ltd (CMS; HKG: 0867) announced its proposal for a secondary listing...
China Medical System Announces Spin-off of Dermavon for HKEX IPO
China Medical System Holdings Limited (CMS; HKG: 0867) has announced the spin-off of its dermatology-focused...
China Medical System’s CMS-D003 Receives NMPA Approval for Clinical Study in oHCM
China Medical System Holdings (CMS; HKG: 0867) announced receiving approval from the National Medical Products...
China Medical System Partners with MabGeek for Innovative Drug MG-K10
China Medical System Holdings (CMS; HKG: 0867) has announced a new license agreement with MabGeek...
China Medical System Licenses Alpha Cognition’s Zunveyl for Dementia Treatment in Asia
China Medical System Holdings (CMS; HKG: 0867) has announced a license agreement with Alpha Cognition...
China Medical System’s Methylthioninium Tablets Receive First Prescriptions for Colonoscopy Use
China Medical System Holdings (CMS; HKG: 0867) has announced that the first prescriptions have been...
China Medical System Holdings Secures Exclusive Rights to Atom Therapeutics’ Gout Drug ABP-671
China Medical System Holdings (CMS; HKG: 0867) has entered into a licensing agreement with compatriot...
China Medical System Holdings Gets NMPA Approval to Test Obesity Treatment CMS-D005
China Medical System Holdings Ltd (CMS, HKG: 0867) has announced that it has received approval...
China Medical System’s Opzelura Approved in Hong Kong for Non-segmental Vitiligo Treatment
China Medical System Holdings (CMS; HKG: 0867) has announced that the market filing for its...
China Medical System’s Opzelura Cream Filing for Vitiligo Accepted by NMPA
China Medical System Holdings (CMS; HKG: 0867) has announced that its market filing for Opzelura...
CMS’s Methotrexate Injection Gains NMPA Approval for Active Rheumatoid Arthritis Treatment
China Medical System Holdings (CMS; HKG: 0867) has received approval from the National Medical Products...
China Medical System’s Methylthioninium Tablets Get NMPA Green Light for Colonoscopy Use
China Medical System Holdings (CMS; HKG: 0867) has announced that it has received New Drug...
China Medical System Secures Exclusive Rights to Baiyiyuan Biotech’s Implant in Greater China
China Medical System Holdings (CMS; HKG: 0867) has entered into a licensing agreement with Shanghai-based...